drugset / Trial / NCT03948737

The Effect of Alpha-tocopherol in Hemolysis and Oxidative Stress Marker on the Red Cell Membrane Beta-thalassemia Major

NCT03948737

Completed 40 enrolled Indonesia University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The accumulation of unpaired α-globin chains in β-thalassemia major patients may clinically create ineffective erythropoiesis, hemolysis, and chronic anemia. Multiple blood transfusions and iron overload cause cellular oxidative damage. However, α-tocopherol, an antioxidant, has been known as a potent scavenger of lipid radicals in the red cell membrane of β-thalassemia major patient. By this randomized controlled trial, the investigators would like to evaluate the effects of α-tocopherol in hemolysis and oxidative stress on the red cell membrane of β-thalassemia major.

Timeline

Start
2016-12-30
Primary completion
2017-07-30
Completion
2017-08-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator alpha-tocopherol Unknown 200 mg Oral
Comparator alpha-tocopherol Unknown 400 mg Oral
Comparator alpha-tocopherol Unknown 600 mg Oral